Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures

NCT03361137 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped The Sponsor decided to terminate the study early for several reasons (low enrollment, limited variety of surgery types, and available scientific data).

Conditions

Interventions

Sponsor

Genentech, Inc.